Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes

被引：47

作者：

Roy, Noemi B. A. ^{[1
]}

Myerson, Saul ^{[2
]}

Schuh, Anna H. ^{[3
]}

Bignell, Patricia ^{[3
]}

Patel, Roger ^{[4
]}

Wainscoat, Jim S. ^{[5
]}

McGowan, Simon ^{[6
]}

Marchi, Emanuele ^{[6
]}

Atoyebi, Wale ^{[5
]}

Littlewood, Tim ^{[5
]}

Chacko, Joseph ^{[7
]}

Vyas, Paresh

Killick, Sally B. ^{[7
]}

机构：

[1] John Radcliffe Hosp, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England

[2] Oxford Radcliffe Hosp, Dept Cardiol, Oxford, England

[3] Oxford Radcliffe Hosp, Haemato Mol Diagnost Serv, Oxford, England

[4] Royal Bournemouth Hosp, Dept Radiol, Bournemouth, Dorset, England

[5] Oxford Radcliffe Hosp, Dept Haematol, Oxford, England

[6] Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England

[7] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2011年 / 154卷 / 04期

关键词：

myelodysplastic syndromes; magnetic resonance imaging; transfusional iron overload; hepatic R2*; cardiac R2*; MAGNETIC-RESONANCE; MYOCARDIAL IRON; ACQUIRED ANEMIAS; THALASSEMIA; CHELATION; DISEASE;

D O I：

10.1111/j.1365-2141.2011.08749.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Transfusion- dependent myelodysplastic (MDS) patients are prone to iron overload. We evaluated 43 transfused MDS patients with T2* magnetic resonance imaging scans. 81% had liver and 16.8% cardiac iron overload. Liver R2* (1000/T2*), but not cardiac R2*, was correlated with number of units transfused (r = 0.72, P < 0.0001) and ferritin (r = 0.53, P < 0.0001). The area under the curve of a time-ferritin plot was found to be much greater in patients with cardiac iron loading (median 53.7 x 10(5) Megaunits vs. 12.2 x 10(5) Megaunits, P = 0.002). HFE, HFE2, HAMP or SLC40A1 genotypes were not predictors of iron overload in these patients.

引用

页码：521 / 524

页数：4

共 50 条

[31] Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
Gattermann, Norbert
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (01) : 24 - 29
[32] Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
Norbert Gattermann
[J]. International Journal of Hematology, 2008, 88 : 24 - 29
[33] Myelodysplastic syndromes and the role of iron overload
Harvey, R. Donald
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (07) : S3 - S9
[34] Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia
Fisher, Sheila A.
Brunskill, Susan J.
Doree, Carolyn
Gooding, Sarah
Chowdhury, Onima
Roberts, David J.
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08):
[35] Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes
Wimazal, F.
Noesslinger, T.
Baumgartner, C.
Sperr, W. R.
Pfeilstoecker, M.
Valent, P.
[J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (05) : 406 - 411
[36] Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)
Angelucci, Emanuele
Santini, Valeria
Di Tucci, Anna Angela
Quaresmini, Giulia
Finelli, Carlo
Volpe, Antonio
Quarta, Giovanni
Rivellini, Flavia
Sanpaolo, Grazia
Cilloni, Daniela
Salvi, Flavia
Caocci, Giovanni
Molteni, Alfredo
Vallisa, Daniele
Voso, Maria Teresa
Fenu, Susanna
Borin, Lorenza
Latte, Giancarlo
Alimena, Giuliana
Storti, Sergio
Piciocchi, Alfonso
Fazi, Paola
Vignetti, Marco
Tura, Sante
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (06) : 527 - 536
[37] Correlation of NT-proBNP levels and cardiac iron concentration in patients with transfusion-dependent thalassemia major
Delaporta, Polyxeni
Kattamis, Antonios
Apostolakou, Filia
Boiu, Sorina
Bartzeliotou, Anastasia
Tsoukas, Evangelos
Papassotiriou, Ioannis
[J]. BLOOD CELLS MOLECULES AND DISEASES, 2013, 50 (01) : 20 - 24
[38] Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy
Pinto, Valeria
Balocco, Manuela
Ambaglio, Ilaria
Derchi, Giorgio
Malcovati, Luca
Forni, Gian Luca
[J]. CLINICAL CASE REPORTS, 2015, 3 (11): : 952 - 954
[39] Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications
Farmaki, Kallistheni
Tzoumari, Ioanna
Pappa, Christina
[J]. BLOOD CELLS MOLECULES AND DISEASES, 2011, 47 (01) : 33 - 40
[40] Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload
Chuansumrit, Ampaiwan
Songdej, Duantida
Sirachainan, Nongnuch
Kadegasem, Praguywan
Saisawat, Pawaree
Sungkarat, Witaya
Kempka, Ketsuda
Tungbubpha, Noppawan
[J]. HEMOGLOBIN, 2024, 48 (01) : 47 - 55

← 1 2 3 4 5 →